Moreover, two benzo[a]phenoxazines that showed high stability in the binding to the G4 in the KIT core promoter, with a preference for KIT2 over KIT1, were able to down-regulate KIT gene expression in human gastric carcinoma cells [71]. The gene discussed is KIT; the disease is gastric carcinoma.